Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toll-like receptors in mediating pathogenesis in systemic sclerosis
Loredana Frasca, Roberto Lande
Clinical & Experimental Immunology (2020) Vol. 201, Iss. 1, pp. 14-24
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Marina Luchner, Sören Reinke, Anita Milicic
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 142-142
Open Access | Times Cited: 216
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis
Dan Fang, Beidi Chen, Alain Lescoat, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 12, pp. 683-693
Closed Access | Times Cited: 54
An insight into the neuroprotective and anti-neuroinflammatory effects and mechanisms of Moringa oleifera
Ummi Kalthum Azlan, Nur Aisyah Khairul Annuar, Ahmed Mediani, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 25
Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity
Marie Dominique Ah Kioon, Paôline Laurent, Vidyanath Chaudhary, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 241-256
Closed Access | Times Cited: 9
The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases
Gricelis Martínez, M Zabaleta, Camilo Di Giulio, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 35, pp. 4467-4485
Closed Access | Times Cited: 68
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit
Vishal Kakkar, Shervin Assassi, Yannick Allanore, et al.
Current Opinion in Rheumatology (2022) Vol. 34, Iss. 6, pp. 357-364
Open Access | Times Cited: 32
Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update
George D. Kalliolias, Efthimia K. Basdra, Athanasios G. Papavassiliou
Biomedicines (2024) Vol. 12, Iss. 1, pp. 138-138
Open Access | Times Cited: 5
Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature
Roberto Lande, Anna Mennella, Raffaella Palazzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5102-5102
Open Access | Times Cited: 39
Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis
Inês S. Silva, Beatriz H. Ferreira, Catarina R. Almeida
Biology (2023) Vol. 12, Iss. 2, pp. 285-285
Open Access | Times Cited: 13
Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
Ju‐Yang Jung, Ji-Won Kim, Chang‐Hee Suh, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 30
Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity
Tugce Karaderi, Halin Bareke, İmge Kunter, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 29
The Role of CXCL4 in Systemic Sclerosis: DAMP, Auto-Antigen and Biomarker
Silvia Porreca, Anna Mennella, Loredana Frasca
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2421-2421
Open Access
Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
Hanna Graßhoff, Konstantinos Fourlakis, Sara Comdühr, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2150-2150
Open Access | Times Cited: 16
Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD
Agnieszka Paradowska‐Gorycka, Anna Wajda, Barbara Stypińska, et al.
Clinical & Experimental Immunology (2020) Vol. 204, Iss. 1, pp. 49-63
Open Access | Times Cited: 23
Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway
Jintao Jiang, Fang Wang, Aishu Luo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 22
CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells
Immacolata Pietraforte, Alessia Butera, Lucia Gaddini, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 653-653
Open Access | Times Cited: 14
Immunogenetics of Systemic Sclerosis
Olga Gumkowska-Sroka, Kacper Kotyla, Przemysław Kotyla
Genes (2024) Vol. 15, Iss. 5, pp. 586-586
Open Access | Times Cited: 2
Characterization of Long Non-Coding RNAs in Systemic Sclerosis Monocytes: A Potential Role for PSMB8-AS1 in Altered Cytokine Secretion
Nila H. Servaas, Barbara Mariotti, Maarten van der Kroef, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4365-4365
Open Access | Times Cited: 15
Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis
Chieh‐Yu Shen, Cheng‐Hsun Lu, Cheng-Han Wu, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3402-3402
Open Access | Times Cited: 14
New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis
Roberto Lande, Raffaella Palazzo, Anna Mennella, et al.
Antibodies (2021) Vol. 10, Iss. 2, pp. 12-12
Open Access | Times Cited: 13
Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis
Yehya Al-Adwi, Isabella M. Atzeni, Berber Doornbos‐van der Meer, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 794-794
Open Access | Times Cited: 4
The Immunogenetics of Systemic Sclerosis
Begüm Ünlü, Ümit Türsen, Zeynab Rajabi, et al.
Advances in experimental medicine and biology (2022), pp. 259-298
Closed Access | Times Cited: 7
The Role of T Cells in Systemic Sclerosis: An Update
Lazaros I. Sakkas, Dimitrios P. Bogdanos
Immuno (2022) Vol. 2, Iss. 3, pp. 534-547
Open Access | Times Cited: 7
Plasma CXCL4–DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment
Anna Mennella, Katia Stefanantoni, Raffaella Palazzo, et al.
Reports — Medical Cases Images and Videos (2024) Vol. 7, Iss. 3, pp. 66-66
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top